{"id":41948,"date":"2016-03-18T09:06:53","date_gmt":"2016-03-18T13:36:53","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=41948"},"modified":"2016-03-18T20:04:55","modified_gmt":"2016-03-19T00:34:55","slug":"esclerodermia-localizada-vs-hemiatrofia-facial","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/41948","title":{"rendered":"Esclerodermia localizada vs. Hemiatrofia facial"},"content":{"rendered":"<p><strong>Dras. Maria Bibiana Leroux<\/strong><br \/>\n<strong>Ver\u00f3nica Estrella<\/strong><br \/>\n<em>Rosario. Argentina<\/em><\/p>\n<p><strong>2004<\/strong><\/p>\n<p>Paciente que comienza con su dermatosis dos a\u00f1os previo a la consulta, localizada en cabeza y cuello.<br \/>\nA los 18 a\u00f1os de edad \/2004\/ presenta dos placas, una en frente lado derecho y otra en zona de maxilar inferior extendida a cuello del mismo lado, ambas con respeto de la l\u00ednea media. Cambios de coloraci\u00f3n caracter\u00edsticos, con m\u00ednima induraci\u00f3n y presencia de atrofia.<br \/>\nBiopsia: esclerosis cut\u00e1nea<br \/>\nANA 1\/40<\/p>\n<p><strong>Se interpreta como:<\/strong><br \/>\n<strong>MORFEA EN PLACAS<\/strong><\/p>\n<p>Debido a que en este momento persiste actividad de la enfermedad.<br \/>\nSe trata con calcipotriol ung\u00fcento t\u00f3pico<br \/>\nVit E 1000 mg\/d<\/p>\n<p>&nbsp;<\/p>\n<a href=\"http:\/\/1drv.ms\/1YNYNch\" target=\"_blank\" class=\"shortc-button medium blue \">CLIC AQUI PARA VER PRESENTACION COMPLETA<\/a>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dras. Maria Bibiana Leroux Ver\u00f3nica Estrella Rosario. Argentina 2004 Paciente que comienza con su dermatosis dos a\u00f1os previo a la consulta, localizada en cabeza y cuello. A los 18 a\u00f1os de edad \/2004\/ presenta dos placas, una en frente lado derecho y otra en zona de maxilar inferior extendida a cuello del mismo lado, ambas &hellip;<\/p>\n","protected":false},"author":51,"featured_media":41949,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[317],"tags":[],"class_list":["post-41948","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-colagenopatia-al-dia"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/41948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/51"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=41948"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/41948\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media\/41949"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=41948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=41948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=41948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}